ARCHIVE

• Meiji Seika Kaisha: Drug Sales Down 6.1% to \110.7 Bil.
  June 17, 2002

• Speed, Quality, Costs Are Main Problems for Clinical Trials in Japan
  June 17, 2002

• Effects of Glivec on GIST Presented
  June 17, 2002

• Kirin: 1st Qtr Drug Sales Up 4.9% to \9.2 Bil.
  June 17, 2002

• Tokyo Area Genomic Network Promotion Council Inaugurated
  June 17, 2002

• Pharmacia Reports PIII Results on Eplerenone
  June 17, 2002

• Kissei: Princeton Bonds Compromise Brings Profits Up
  June 10, 2002

• CMIC to Be Listed on JASDAQ
  June 10, 2002

• MBL Forms Strategic Alliance with Beckman Coulter
  June 10, 2002

• Nikken Chemical: Sales Down 4.4% to \54.8 Bil.
  June 10, 2002

• Interest in Generics Is Increasing: EMA President
  June 10, 2002

• DIAGNOSTIC NEWS IN BRIEF
  June 10, 2002

• Torii: Sales, Profits Down Due to Futhan Generics
  June 10, 2002

• BUSINESS NEWS IN BRIEF
  June 10, 2002

• WORLD NEWS IN BRIEF
  June 10, 2002

• Toyama Chemical: Sales Down 22.7% Due to Slump of Mainstays
  June 10, 2002

• Landiol for Tachyarrhythmia 1Recommended for Approval
  June 10, 2002

• Shionogi: Net Profits Plummet 33% Due to Restructuring
  June 10, 2002

• Kyowa Hakko: Drug Sales Up 0.6% to \142.2 Bil.
  June 10, 2002

• Korosho to Accelerate Approval of Overseas Anticancer Agents
  June 10, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 673
• 674
• 675
• 676
• 677
• 678
• 679
• 680
• 681
• …
• Next ›
• 最終 »